SEC EDGAR · Company announcement
HCA: Financial results · Company disclosure · Other company developments
Filed 8-K for an event or period dated 2026-10-27. Financial results; Company disclosure; Other company developments.
Follow HCA- Became public
- Oct 27, 2026, 7:17 AM EDT
- Event / period date
- Oct 27, 2026
- Collected
- Nov 7, 2026, 8:46 PM EST
Why this is connected
This filing identifies HCA Healthcare, Inc. as the issuer of the security. The company's SEC identifier connects it to HCA.
Press Release, dated October 27, 2026 ↗Source evidence
Read the source excerpt or record
Item 2.02. Results of Operations and Financial Condition. On October 27, 2026, HCA Healthcare, Inc. (the “Company”) issued a press release announcing, among other matters, its results of operations for the third quarter ended September 30, 2026, the text of which is set forth as Exhibit 99.1 . Item 7.01. Regulation FD Disclosure. On October 27, 2026, the Company issued a press release announcing, among other matters, its results of operations for the third quarter ended September 30, 2026, the text of which is set forth as Exhibit 99.1 . Item 8.01. Other Events. On October 27, 2026, the Company announced that its Board of Directors had declared a quarterly cash dividend of $0.78 per share of the Company’s common stock. The dividend will be paid on December 29, 2026 to stockholders of record at the close of business on December 15, 2026. Item 9.01. Financial Statements and Exhibits. (d) Exhibits: Exhibit 99.1 Press Release, dated October 27, 2026 Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HCA HEALTHCARE, INC. Date: October 27, 2026 By: /s/ Michael A. Marks Michael A. Marks Executive Vice President and Chief Financial Officer
Congressional trading in HCA
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Jul 26, 2026$1K–$15K
Rep. Jared Moskowitz (D-FL-23)
$1K–$15K · Traded Jun 17, 2026 · disclosed Jul 26, 2026
- Jul 26, 2026$1K–$15K
Rep. Jared Moskowitz (D-FL-23)
$1K–$15K · Traded Jun 17, 2026 · disclosed Jul 26, 2026 · Dependent
- Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Oct 22, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
$1K–$15K · Traded Sep 11, 2025 · disclosed Oct 22, 2025 · Spouse
- Sep 12, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
$1K–$15K · Traded Aug 19, 2025 · disclosed Sep 12, 2025 · Spouse
- Sep 12, 2025$1K–$15K
Rep. Val T. Hoyle (D-OR-4)
$1K–$15K · Traded Dec 27, 2024 · disclosed Sep 12, 2025 · Spouse · filed 259 days later
- Sep 12, 2025$1K–$15K
Rep. Val T. Hoyle (D-OR-4)
$1K–$15K · Traded Oct 29, 2024 · disclosed Sep 12, 2025 · Spouse · filed 318 days later
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.